NCT04632862View on ClinicalTrials.gov

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

November 25, 2021

Study Completion Date

November 25, 2021

Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG

DWP16001

DWP16001 A mg

Trial Locations (1)

Unknown

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY